Patent Assignment
Reel/Frame 028884/0151
Change of Name
Recorded: 2012-08-30
Pages: 28
Assignor
SCHERING CORPORATION
Executed: 2012-05-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(862)
Cdna Clones Coding for Human Protein Exhibiting a Broad Cellular Activity Spectrum (Human Interleukin-4)
Patent:
5,552,304 →
Application:
06/843,958 →
Actinomadura Vulgaris Subsp Vulgaris and Antimicrobial Complex and Antimicrobial
Patent:
5,837,691 →
Application:
07/747,456 →
Lipoxygenase Inhibitors
Patent:
5,563,292 →
Application:
07/847,071 →
Heterocyclic Substituted Naphthyridinones and Methods and Compositions Employing Them
Patent:
5,760,034 →
Application:
07/852,214 →
Stable Cream and Lotion Bases for Lipophilic Drug Compositions
Patent:
5,422,361 →
Application:
07/859,494 →
Bis-Benzo or Benzopyrido Cyclohepta Piperidene, Piperidylidene and Piperazine Compounds, Compositions and Methods of Use
Patent:
5,422,351 →
Application:
07/949,810 →
Stable Extended Release Oral Dosage Composition Comprising Loratadine and Pseudoephedrine
Patent:
5,314,697 →
Application:
07/965,470 →
Mometasone Furoate Monohydrate, Process for Making Same and Pharmaceutical Compositions
Patent:
6,127,353 →
Application:
07/984,573 →
Stabilization of Protein Formulations
Patent:
5,358,708 →
Application:
08/011,431 →
Metal-Interferon-Alpha Crystals
Patent:
5,441,734 →
Application:
08/024,330 →
Purification of Human Interleukin-10 from a Cell Culture Medium
Patent:
5,328,989 →
Application:
08/026,942 →
Process for Preparing Florfenicol, Its Analogs and Oxazoline Intermediates Thereto
Patent:
5,382,673 →
Application:
08/039,450 →
Method of Purifying Protein
Patent:
5,451,662 →
Application:
08/105,994 →
Process for Preparing Isepamicin
Patent:
5,442,047 →
Application:
08/138,558 →
Non-Chlorofluorocarbon Aerosol Formulations
Patent:
5,474,759 →
Application:
08/157,182 →
Tricyclic Derivatives, Compositions and Methods of Use
Patent:
5,574,173 →
Application:
08/162,686 →
Process for Preparing Intermediates for the Synthesis of Antifungal Agents
Patent:
5,349,099 →
Application:
08/166,332 →
Inhalation Device for Powdered Medicaments
Patent:
5,394,868 →
Application:
08/167,811 →
Treatment of Neoplastic Disease with Interleukin-10
Patent:
6,106,823 →
Application:
08/170,113 →
Humanized Monoclonal Antibodies Against Human Interleukin-4
Patent:
5,597,710 →
Application:
08/208,886 →
Method of Reducing Immunoglobulin E Responses
Patent:
5,676,940 →
Application:
08/210,649 →
4-Substituted Pyrazoloquinoline Derivatives
Patent:
5,608,067 →
Application:
08/234,695 →
Process for Preparing Intermediates for the Synthesis of Antifungal Agents
Patent:
5,442,093 →
Application:
08/239,488 →
Imidazoylalkyl Substituted with a Six Membered Nitrogen Containing Heterocyclic Ring
Patent:
5,807,872 →
Application:
08/244,830 →
Process for Preparing Flunixin and Intermediates Thereof
Patent:
5,484,931 →
Application:
08/244,883 →
Purified Mammalian Ctla-8 Antigens and Related Reagents
Patent:
6,562,333 →
Application:
08/250,846 →
Process for Preparing Delta 9,11 and 21-Chloro Corticosteroids
Patent:
5,502,222 →
Application:
08/252,302 →
Hydroxy-Substituted Azetidinone Compounds Useful as Hypocholesterolemic Agents
Patent:
5,631,365 →
Application:
08/257,593 →
Process for the Preparation of Chiral Intermediates Useful for the Synthesis of Antifungal Agents
Patent:
5,486,625 →
Application:
08/272,411 →
Humanized Monoclonal Antibodies Against Human Interleukin-5
Patent:
6,056,957 →
Application:
08/284,516 →
Process for Recover Halocarbons from Liquid Waste Slurries
Patent:
5,595,661 →
Application:
08/285,254 →
Humanized Monoclonal Antibodies Against Human Interleukin-4
Patent:
5,863,537 →
Application:
08/290,793 →
Bridged Bis-Aryl Carbinol Derivatives, Compositions and Methods of Use
Patent:
5,561,117 →
Application:
08/307,714 →
Unbridged Bis-Aryl Carbinol Derivatives, Compositions and Methods of Use
Patent:
5,679,692 →
Application:
08/307,801 →
Stable Hydrated Cephalosporin Dry Powder for Oral Suspension Formulation
Patent:
5,599,557 →
Application:
08/325,400 →
Mammalian Thymokine Genes
Patent:
5,786,210 →
Application:
08/329,704 →
Stable, Aqueous Alfa Interferon Solution Formulations
Patent:
5,766,582 →
Application:
08/329,813 →
Pentacyclic Antihistamines
Patent:
5,648,360 →
Application:
08/335,885 →
Interferon Polymer Conjugates
Patent:
5,711,944 →
Application:
08/337,567 →
Monoclonal Antibodies Against Human Interleukin-4 and Hybridomas Producing the Same
Patent:
5,912,136 →
Application:
08/355,415 →
Methods for Producing Metal-Interferon-Alpha Crystals
Patent:
5,602,232 →
Application:
08/356,021 →
Pyrazoloquinolines
Patent:
5,597,821 →
Application:
08/356,826 →
Pyrazoloquinolines
Patent:
5,595,998 →
Application:
08/357,624 →
Human Interleukin-4 Immunopurification Processes
Patent:
5,700,915 →
Application:
08/366,391 →
Use of Gm-Csf as a Vaccine Adjuvant
Patent:
5,679,356 →
Application:
08/367,114 →
Diindolo Compounds and Pharmaceutical Compositions Containing Them
Patent:
5,589,472 →
Application:
08/397,205 →
Methods of Treating Insulin-Dependent Diabetes Mellitus by Administration of Il-10
Patent:
5,827,513 →
Application:
08/406,929 →
Mometasone Furoate Monohydrate, Process for Making Same and Pharmaceutical Compositions
Patent:
6,180,781 →
Application:
08/422,479 →
Chiral Hydrazine Derivatives
Patent:
5,616,777 →
Application:
08/425,129 →
Purified Mammalian Ctla-8 Antigens and Related Reagents
Patent:
6,274,711 →
Application:
08/432,994 →
Benzo[5,6]Cycloheptapyridines, Compositions and Methods of Use
Patent:
5,665,726 →
Application:
08/433,300 →
E. Coli Secretory Strains
Patent:
5,578,464 →
Application:
08/438,803 →
Soluble Active Hepatitis C Virus Protease
Patent:
5,843,752 →
Application:
08/440,409 →
Combination Therapy for Chronic Hepatitis C Infection
Patent:
6,387,365 →
Application:
08/444,584 →
Inhaler for Powdered Medications
Patent:
5,829,434 →
Application:
08/446,804 →
Process for Preparing DELTA9,11 and 21-Chloro Corticosteroids
Patent:
5,616,742 →
Application:
08/446,982 →
Process for Preparing Flunixin and Intermediates Thereof
Patent:
5,965,735 →
Application:
08/448,152 →
Spriocycloalkyl-Substituted Azetidinones Useful as Hypocholesterolemic Agents
Patent:
5,698,548 →
Application:
08/449,980 →
Catalytic Enantioselective Synthesis of a Spriofused Azetidinone
Patent:
5,648,484 →
Application:
08/451,111 →
Highly Purified Species of Human Leukocyte Interferon
Patent:
6,117,423 →
Application:
08/452,626 →
Human Interleukin-4 Antagonist/Agonist Screens
Patent:
5,958,707 →
Application:
08/453,024 →
Process for Preparation of 9X-Chloro-11B Formyloxypregna-3.20-Diones
Patent:
5,670,676 →
Application:
08/455,967 →
Tetrahydrofuran Antifungals
Patent:
5,714,490 →
Application:
08/458,543 →
Process for the Preparation of Triazolones
Patent:
5,625,064 →
Application:
08/458,550 →
Tetrahydrofuran Antifungals
Patent:
5,703,236 →
Application:
08/458,551 →
Inhaler for Powdered Medications Having Spiral Deagglomeration Chamber
Patent:
5,687,710 →
Application:
08/458,928 →
Tetrahydrofuran Antifungals
Patent:
5,693,626 →
Application:
08/459,145 →
Unbridged Bis-Aryl Carbinol Derivatives Compositions and Methods of Use
Patent:
5,665,735 →
Application:
08/459,149 →
Tetrahydrofuran Antifungals
Patent:
5,710,154 →
Application:
08/459,225 →
Tetrahydrofuran Antifungals
Patent:
5,703,079 →
Application:
08/460,400 →
Inhaler for Powdered Medications with Gear-Teeth Counter Assembly
Patent:
5,740,792 →
Application:
08/460,604 →
Tetrahydrofuran Antifungals
Patent:
5,661,151 →
Application:
08/460,752 →
Method of Preparing Polypeptide Binding Compositions Derived from Immunoglobulin Variable Regions
Patent:
5,851,801 →
Application:
08/460,892 →
Hybrid Dna Prepared Binding Composition
Patent:
5,840,545 →
Application:
08/461,071 →
Cytokine Synthesis Inhibitory Factor, (Il-10) and Pharmaceutical Compositions Thereof
Patent:
6,217,857 →
Application:
08/464,110 →
Interleukin-10 (Il-10)
Patent:
6,239,260 →
Application:
08/467,365 →
Methods of Treatment using Antagonists of Cytokine Synyhesis Inhibitory Factor
Patent:
6,207,154 →
Application:
08/467,374 →
Method of Using Interleukin-4
Patent:
5,656,266 →
Application:
08/468,734 →
Fused Polypeptides Comprising Interleukin-4 Polypeptide Fragments
Patent:
5,807,996 →
Application:
08/468,735 →
Nucleic Acids Encoding Human Interleukin-4
Patent:
5,955,315 →
Application:
08/468,817 →
Pharmaceutical Compositions Comprising Human Interleukin-4 (Il-4)
Patent:
5,730,970 →
Application:
08/469,267 →
Cloning and Expression of Humanized Monoclonal Antibodies Against Human Interleukin-4
Patent:
5,770,403 →
Application:
08/469,557 →
Mammalian Thymokine Having Leukocyte Chemotactic Activity,and Fragments Thereof
Patent:
5,877,285 →
Application:
08/472,604 →
Tricyclic Derivatives, Compositions and Methods of Use
Patent:
5,767,120 →
Application:
08/479,418 →
Crystalline R-H-Gm-Csf and Method
Patent:
5,616,555 →
Application:
08/482,168 →
Antibodies Which Specifically Bind to the Thymokine Lymphotactin
Patent:
5,985,580 →
Application:
08/486,117 →
Purification of Bacterially Expressed Human Interleukin-10
Patent:
5,710,251 →
Application:
08/495,558 →
Stereoselective Microbial Reduction of 5-Fluorophenyl-5-Oxo-Pentanoic Acid and a Phenyloxazolidinone Condensation Product Thereof
Patent:
5,618,707 →
Application:
08/583,166 →
Carbonyl Piperazinyl and Piperidinyl Compounds
Patent:
5,880,128 →
Application:
08/646,835 →
Dna Encoding Mammalian CX3C Chemokine Genes
Patent:
6,548,654 →
Application:
08/649,006 →
3-Hydroxy Gamma-Lactone Based Enantionselective Synthesis of Azetidinones
Patent:
5,739,321 →
Application:
08/655,785 →
Hydroxy-Substituted Antifungals
Patent:
5,698,557 →
Application:
08/664,758 →
Method of Treatment of Acute Leukemia with Inteleukin-10
Patent:
5,770,190 →
Application:
08/670,298 →
Process for Preparing Intermediates to Florfenicol
Patent:
5,663,361 →
Application:
08/699,271 →
Humanized Monoclonal Antibodies Against Human Interleukin-4
Patent:
5,705,154 →
Application:
08/704,744 →
Borrelia Burgdorferi Bacterin
Patent:
6,316,005 →
Application:
08/722,013 →
Process for Preparing Delta 9,11 and 21-Chloro Corticosteroids
Patent:
5,750,745 →
Application:
08/737,690 →
Sugar-Substituted 2-Azetidinones Useful as Hypocholesterolemic Agents
Patent:
5,756,470 →
Application:
08/741,179 →
Process for Preparing 1-(4-Fluorophenyl)-3(R)-(3(S)-Hydroxy-3-[Phenyl or 4-Fluorophenyl])-Propyl)-4(S)-(4-Hydroxyphenyl)-2-Azetidinone
Patent:
5,856,473 →
Application:
08/742,012 →
2'-[[4'-Halo-[1,1'-Biphenyl]-4-Yl]Methyl]-5'-Methyl-Spiro[Cyclopentane -1,7'(8'H)-[3H]Imidazo[2,1-B]Purin]-4'(5'H)-Ones
Patent:
5,824,683 →
Application:
08/756,508 →
Process for Preparing Intermediates for the Synthesis of Antifungal Agents
Patent:
5,756,830 →
Application:
08/766,441 →
Process for Preparation of Hydrazides
Patent:
5,684,197 →
Application:
08/766,442 →
Tricyclic Amides Useful for Inhibition of G-Protein Function and for Treatment of Proliferative Disease
Patent:
5,874,442 →
Application:
08/766,601 →
Lipophilic Oligosaccharide Antibiotic Compositions
Patent:
5,776,912 →
Application:
08/770,470 →
Powdered Medication Inhaler
Patent:
6,240,918 →
Application:
08/803,363 →
Porcine Reproductive and Respiratory Syndrome Vaccine
Patent:
5,866,401 →
Application:
08/805,087 →
Use of Mometasone Furoate for Treating Upper Airway Passage Diseases
Patent:
5,837,699 →
Application:
08/821,135 →
Polyethylene Glycol Modified Interferon Therapy
Patent:
5,908,621 →
Application:
08/839,101 →
Expression of Soluble Heterologous Proteins in Bacteria Utilizing a Thioredoxin/Protein Expression Vector
Patent:
7,655,436 →
Application:
08/846,606 →
Antifungal Composition with Enhanced Bioavailabilty
Patent:
5,834,472 →
Application:
08/861,250 →
3-Hydroxy Gamma-Lactone Based Enantioselective Synthesis of Azetidinones
Patent:
5,886,171 →
Application:
08/864,529 →
Naphthyridines Which Affect Il-4 and G-Csf
Patent:
5,939,431 →
Application:
08/878,860 →
Process for the Preparationof 17-Esters of 9 Alpha, 21-Dihalo-Pregnane-11 Beta, 17 Alpha-Diol-20-Ones
Patent:
5,886,200 →
Application:
08/881,811 →
Mammalian Tnf-Alpha Convertases
Patent:
5,853,977 →
Application:
08/889,909 →
Cancer Treatment with Temozolomide
Patent:
5,939,098 →
Application:
08/902,380 →
Method for Treating Pediatric High Grade Astrocytoma Including Brain Stem Glioma
Patent:
5,942,247 →
Application:
08/902,381 →
Use of Mometasone Furoate for Treating Lower Airway Passage and Lung Diseases
Patent:
5,889,015 →
Application:
08/911,300 →
Mammalian Cell Surface Antigens; Related Reagents
Patent:
6,111,090 →
Application:
08/911,423 →
Chlorofluorocarbon-Free Mometasone Furoate Aerosol Formulations
Patent:
6,068,832 →
Application:
08/920,611 →
Novel Tricyclic Piperidinyl Compounds Useful as Inhibitors of Farnesyl-Protein Transferase
Patent:
5,965,570 →
Application:
08/927,729 →
Combination Therapy for Eradicating Detectable Hcv-Rna in Patients Having Chronic Hepattis C Infection
Patent:
6,172,046 →
Application:
08/938,033 →
Combinations of Hydroxy-Substituted Azetidinone Compounds and Hmg Co-a Reductase Inhibitors
Patent:
5,846,966 →
Application:
08/953,825 →
Ig Superfamily 'Dlair' Receptors in Monocytes
Patent:
6,140,076 →
Application:
08/985,950 →
Methods for Purifying Viruses
Patent:
6,261,823 →
Application:
08/989,227 →
Mammalian Cell Surface Antigens: Related Reagents
Patent:
6,242,586 →
Application:
08/989,362 →
Methods for Cultivating Cells and Propagating Viruses
Patent:
6,168,944 →
Application:
09/020,572 →
Surface Plasmon Resonance Based Enzymatic Assay
Patent:
5,981,167 →
Application:
09/021,480 →
Method for Producing and Screening Mass Coded Combinatorial Libraries for Drug Discovery and Target Validation
Patent:
6,207,861 →
Application:
09/024,592 →
Synthesis of Intermediates Useful in Preparing Tricyclic Compounds
Patent:
5,998,620 →
Application:
09/045,803 →
Stabilized Antihistamine Syrup
Patent:
6,132,758 →
Application:
09/088,128 →
Stable Aqueous Alfa Interferon Solution Formulations
Patent:
5,935,566 →
Application:
09/096,708 →
Nucleic Acids Encoding a Cysteine Rich Protein
Patent:
6,503,730 →
Application:
09/099,898 →
Nucleic Acids Encoding Mammalian Cell Membrane Protein Mdl-1
Patent:
6,416,973 →
Application:
09/127,946 →
Mammalian Tnf-Alpha Convertases
Patent:
6,319,681 →
Application:
09/156,163 →
Tetrahydrofuran Antifungal Phosphate
Patent:
6,043,245 →
Application:
09/160,997 →
Crystalline Antifungal Polymorph
Patent:
6,713,481 →
Application:
09/166,445 →
Memetasone Furoate Suspensions for Nebulization
Patent:
6,187,765 →
Application:
09/167,512 →
Tricyclic Amides Useful for Inhibition of G-Protein Function and for Treatment of Proliferative Diseases
Patent:
6,143,758 →
Application:
09/190,338 →
Tricyclic Amides Useful for Inhibition of G-Protein Function and for Treatment of Proliferative Diseases
Patent:
6,214,828 →
Application:
09/190,362 →
Thrombin Receptor Antagonists
Patent:
6,063,847 →
Application:
09/197,442 →
Single-Chain Recombinant Complexes of Hepatitis C Virus NS3 Protease and NS4A Cofactor Peptide
Patent:
6,211,338 →
Application:
09/198,723 →
3-Hydroxy Gamma-Lactone Based Enantioselective Synthesis of Azetidinones
Patent:
6,096,883 →
Application:
09/210,921 →
Molecular Dispersion Composition with Enhanced Bioavailability
Method for Treating Proliferative Diseases
Patent:
6,096,757 →
Application:
09/217,335 →
Method for Identifying Compounds in a Chemical Mixture
Patent:
6,147,344 →
Application:
09/233,794 →
Compostions Comprising Viruses and Methods for Concentrating Virus Preparations
Patent:
6,544,769 →
Application:
09/249,646 →
Stereoselective Microbial Reduction for the Preparation of 1-(4-Fluorophenyl)-3(R)-[3(S)-Hydroxy-3-(4-Fluorophenyl)Propyl)]-4-(S) -(4-Hydroxyphenyl)-2-Azetidinone
Patent:
6,133,001 →
Application:
09/256,029 →
Use of Mometasone Furoate for Treating Airway Passage and Lung Diseases
Patent:
6,057,307 →
Application:
09/259,721 →
Polynucleotides Encoding DIRS1
Patent:
6,586,228 →
Application:
09/265,540 →
Formulations for Protection of Peg-Interferon Alpha Conjugates
Patent:
6,180,096 →
Application:
09/268,423 →
Polyethylene Glycol Modified Interferon Therapy
Patent:
6,177,074 →
Application:
09/281,401 →
Novel Peptide Substrates for Hcv NS3 Protease Assays
Patent:
6,251,583 →
Application:
09/288,391 →
Combination Therapy for Eradicating Detectable Hcv-Rna in Antiviral Treatment Naive Patients Having Chronic Hepatitis C Infection
Patent:
6,472,373 →
Application:
09/311,487 →
8-Chloro-6,11-Dihydro-11-(4-Piperidylidine)-5H-Benzo[5,6]Cyclohepta [1,2-B]Pyridine Oral Compositions
Patent:
6,100,274 →
Application:
09/348,943 →
High Affinity Ligands for Nociceptin Receptor Orl-1
Patent:
6,262,066 →
Application:
09/359,771 →
Crystallizable Farnesyl Protein Transferase Compositions, Crystals Thereby Obtained, and Methods for Use
Patent:
6,539,309 →
Application:
09/364,182 →
Enantioselective Synthesis
Patent:
6,262,270 →
Application:
09/371,172 →
Method for Producing and Screening Mass-Coded Combinatorial Libraries for Drug Discovery and Target Validation
Patent:
6,714,875 →
Application:
09/373,018 →
Crystalline Farnesyl Protein Transferase Compositions and Methods for Use
Patent:
6,535,820 →
Application:
09/383,364 →
Methods and Compositions for Treating Sinusitis, Otitis Media and Other Related Disorders Using Corticosteroids
Patent:
6,297,227 →
Application:
09/391,797 →
Polynucleotide Encoding a Histamine Receptor
Patent:
6,204,017 →
Application:
09/414,010 →
Methods for Conversion of Protein Isoforms
Patent:
6,281,337 →
Application:
09/441,653 →
Enantioselective Alkylation of Tricyclic Compounds
Patent:
6,307,048 →
Application:
09/442,511 →
Synthesis of Intermediates Useful in Preparing Tfricyclic Compounds
Patent:
6,372,909 →
Application:
09/442,512 →
Methods of Using Temozolomide in the Treatment of Cancers
Patent:
6,251,886 →
Application:
09/453,747 →
Process for the Synthesis of Azetidinones
Patent:
6,207,822 →
Application:
09/455,482 →
Process for Preparing Tricyclic Compounds Having Antihistaminic Activity
Patent:
6,271,378 →
Application:
09/464,572 →
Il-17-Like Cytokine Binding Compounds and Antibodies
Patent:
6,562,578 →
Application:
09/480,297 →
Method of Preparing Particles for Agglomeration
Patent:
6,623,760 →
Application:
09/490,796 →
Methods for treating proliferative diseases
Patent:
6,333,333 →
Application:
09/503,513 →
Improved cancer treatment with temozolomide
Patent:
6,346,524 →
Application:
09/535,182 →
Use of mometasone furoate for treating airway passage and lung diseases
Patent:
6,365,581 →
Application:
09/535,208 →
Compositions of Hepatitis C Virus NS5B Polymerase and Methods for Crystallizing Same
Patent:
6,434,489 →
Application:
09/541,990 →
Compositions of Hepatitis C Virus NS3/NS4A Complex and Methods for Crystallizing Same
Patent:
6,524,589 →
Application:
09/543,376 →
CML Therapy
Patent:
6,362,162 →
Application:
09/545,311 →
Thrombin receptor antagonists
Patent:
6,326,380 →
Application:
09/545,720 →
Mammalian Cell Surface Antigens; Related Reagents
Patent:
7,025,962 →
Application:
09/545,998 →
Antibodies That Specifically Bind Dnax Leukocyte Associated Immunoglobulin-Like Receptor (Dlair)
Patent:
6,479,638 →
Application:
09/546,049 →
Hcv Combination Therapy
Patent:
6,849,254 →
Application:
09/551,341 →
Mammalian Cytokine; Related Reagents
Patent:
6,495,667 →
Application:
09/558,087 →
Il-B30 Proteins
Patent:
6,479,634 →
Application:
09/558,089 →
Method for Detecting Il-B30 Polynucleotides
Patent:
6,835,825 →
Application:
09/558,474 →
Piperazine Derivatives Useful as CCR5 Antagonists
Patent:
6,391,865 →
Application:
09/562,814 →
Piperidine derivatives useful as CCR5 antagonists
Patent:
6,387,930 →
Application:
09/562,815 →
Combination therapy for chronic hepatitis c infection
Patent:
6,299,872 →
Application:
09/563,649 →
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
Patent:
37,721 →
Application:
09/594,996 →
Method for Identifying Compounds in a Chemical Mixture
Patent:
6,581,013 →
Application:
09/629,282 →
Muscarinic antagonists
Patent:
6,294,554 →
Application:
09/651,652 →
Mammalian Cytokines; Related Reagents and Methods
Patent:
7,090,847 →
Application:
09/658,699 →
Enantioselective alkylation of tricyclic compounds
Patent:
6,288,233 →
Application:
09/667,411 →
Antibodies to Mammalian T Cell Surface Antigen
Patent:
6,525,180 →
Application:
09/671,658 →
Single-Chain Recombinant Complexes of Hepatitis C Virus NS3 Protease and NS4A Cofactor Peptide
Patent:
6,653,127 →
Application:
09/684,881 →
Process for Preparing Beclomethasone Dipropionate Freon Clathrate
Patent:
6,436,368 →
Application:
09/690,388 →
Polyethylene Glycol Modified Interferon Therapy
Patent:
6,524,570 →
Application:
09/699,663 →
Formulations for protection of peg-interferon alpha conjugates
Patent:
6,250,469 →
Application:
09/703,581 →
Process for preparing N-(4-hydroxyphenyl)-N'-(4'-aminophenyl)-piperazine
Patent:
6,355,801 →
Application:
09/707,018 →
Methods of Inhibiting Metastasis
Patent:
6,949,243 →
Application:
09/721,613 →
Selective Neurokinin Antagonists
Everninomicin Biosynthetic Genes
Treating Allergic and Inflammatory Conditions
High Affinity Ligands for Nociceptin Receptor Orl-1
Mammalian CX3C Chemokine Genes
Polynucleotides Encoding a Mammalian Langerhans Cell Antigen
Patent:
6,878,528 →
Application:
09/787,192 →
Chemokine Receptor Antagonists
Preparation of Powder Agglomerates
Hepatitis C Virus NS3 Helicase Subdomain I
Hcv Replicase Complexes
Methods of Modulating Il- 174 Response
Il-23 Receptor Binding Compositions
Isolated Mammalian Membrane Protein Genes; Related Reagents
Adenosine A2A Receptor Antagonists
Monocyte-Derived Homolog of FDF03 Protein
Patent:
6,774,214 →
Application:
09/869,388 →
Nor-Seco Himbacine Derivatives Useful as Thrombin Receptor Antagonists
Synthesis of Intermediates Useful in Preparing Tricyclic Compounds
Stabilized Antihistamine Syrup
Preparation of Powder Agglomerates
Renal Cell Carcinoma Treatment
Melanoma Therapy
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
7 Transmembrane Receptor Family Member Blrx
Nucleic Acids Encoding Ctla-8; and Related Reagents
Dna Encoding Interleukin-B30
Patent:
39,015 →
Application:
09/935,366 →
Xanthine Phosphodiesterase V Inhibitors
Antibodies Binding the Tnf Related Protein,Tnf-X
Pegylated Interleukin-10
Binding Compounds for Il-27
Mammalian Cytokines; Receptors; Related Reagents and Methods
Piperidine Derivatives Useful as CCR5 Antagonists
Muscarinic Antagonists
Patent:
6,458,812 →
Application:
10/023,277 →
Heteroaryl Urea Neuropeptide Y Y5 Receptor Antagonists
Use of Mometasone Furoate for Treating Airway Passage and Lung Diseases
Synthesis of Temozolomide and Analogs
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Use of Mometasone Furoate for Treating Airway Passage and Lung Diseases
Treatment of Malaria with Farnesyl Protein Transferase Inhibitors
Use of Substituted Azetidinone Compounds for the Treatment of Sitosterolemia
Piperazine Derivatives Useful as CCR5 Antagonists
Cannabinoid Receptor Ligands
Continuous Low-Dose Cytokine Infusion Therapy
Patent:
6,461,605 →
Application:
10/104,287 →
Enantioselective Synthesis of Azetidinone Intermediate Compounds
Method for Producing and Screening Mass-Coded Combinatorial Libraries for Drug Discovery and Target Validation
Method for Producing and Screening Mass-Coded Combinatorial Libraries for Drug Discovery and Target Validation
Method for Producing and Screening Mass-Coded Combinatorial Libraries for Drug Discovery and Target Validation
Sterol Absorption Inhibitor Compositions
Method of Treating Androgen-Dependent Disorders
Mammalian Tnf-Alpha Convertases
CCL27 Polypeptides
High Affinity Ligands for Nociceptin Receptor Orl-1
Selective Neurokinin Antagonists
Substituted 2-Azetidinones Useful as Hypocholesterolemic Agents
Stable Extended Release Oral Dosage Composition
Extended Release Oral Dosage Composition
Heteroaryl Urea Neuropeptide Y Y5 Receptor Antagonists
Antibodies and Fragments Thereof to Mdl-1 Protein
Novel Gamma Secretase Inhibitors
Cannabinoid Receptor Ligands
Process of Synthesis of a Tricyclic Ketone Intermediate
Polycyclic Guanine Phosphodiesterase V Inhibitors
17 Beta-Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Binding Compounds Specific for Cysteine-Rich Soluble Protein C23
C23 Polypeptides
Methods and Therapeutic Combinations for the Treatment of Xanthoma Using Sterol Absorption Inhibitors
Methods and Therapeutic Combinations for the Treatment of Diabetes Using Sterol Absorption Inhibitors
Methods and Therapeutic Combinations for the Treatment of Obesity Using Sterol Absorption Inhibitors
Muscarinic Antagonists
Adenosine A2A Receptor Antagonists
3,4-Di-Substituted Maleimide Compounds as Cxc Chemokine Receptor Antagonists
Synthesis of 4-[(Z)-4-Bromophenyl)(Ethoxyimino) Methyl]-1'-[(2,4-Dimethyl-1-Oxido-3-Pyridinyl)Carbonyl]-4'-Methyl-1,4-'Bipiperidine
17-Beta Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Thrombin Receptor Antagonists
Mch Antagonists for the Treatment of Obesity
Ribavirin Syrup Formulations
Polycyclic Guanine Derivative Phosphodiesterase V Inhibitors
Cannabinoid Receptor Ligands
Stabilized Antihistamine Syrup
Adenosine A2A Receptor Antagonists
Adenosine A2A Receptor Antagonists
[1,2,4]-Triazole Bicyclic Adenosine A2A Receptor Antagonists
Compounds for the Treatment of Inflammatory Disorders
Mammalian Cell Surface Antigens; Related Reagents
Novel Compounds as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Purified Mammalian Cytokines; Related Reagents and Methods
Pharmaceutical Formulations of Antineoplastic Agents and Processes of Making and Using the Same
Mammalian Genes; Related Reagents and Methods
Method for Producing and Screening Mass-Coded Combinatorial Libraries for Drug Discovery and Target Validation
Anti-Mammalian CX3C Cytokine Antibodies
Patent:
7,115,379 →
Application:
10/397,559 →
Human Monoclonal Antibodies to Interleukin-5
G-Protein Coupled Receptor Ligands and Methods
DIRS1 Antibodies
Thrombin Receptor Antagonists
Benzimidazolone Histamine H3 Antagonists
Muscarinic Antagonists
Use of Mometasone Furoate for Treating Airway Passage and Lung Diseases
Neutralizing Human Anti-Igfr Antibody
Codon-Optimized B-Secretase and Methods of Refolding and Processing
Patent:
7,166,454 →
Application:
10/443,949 →
Modified Tumor Necrosis Factor-Alpha Converting Enzyme and Methods of Use Thereof
Patent:
7,138,264 →
Application:
10/444,257 →
Adenosine A2A Receptor Antagonists
Thrombin Receptor Antagonists
Cannabinoid Receptor Agonists
Histamine Receptor Antibody
3,4-Di-Substituted Cyclobutene-1,2-Diones as Cxc-Chemokine Receptor Ligands
Selective D1/D5 Receptor Antagonists for the Treatment of Obesity and Cns Disorders
Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Novel Pyrazolopyridines as Cyclin Dependent Kinase Inhibitors
Novel Imidazopyridines as Cyclin Dependent Kinase Inhibitors
Imidazopyrazines as Cyclin Dependent Kinase Inhibitors
Nucleic Acids Encoding DCRS5
DCRS5 Polypeptides
Piperazine Derivatives Useful as CCR5 Antagonists
Thrombin Receptor Antagonists
Enantioselective Process
Il-1-Like Cytokine Antibodies
Extended Release Oral Dosage Composition
Uses of Il-174 for Treating Helminth Infections
17BETA-Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Compounds for the Treatment of Inflammatory Disorders
Mammalian Receptor Protein DCRS5;Methods of Treatment
Cannabinoid Receptor Ligands
NPC1L1 (NPC3) and Methods of Use Thereof
Adenosine A2A Receptor Antagonists for the Treatment of Extra-Pyramidal Syndrome and Other Movement Disorders
Methods of Modulating Ifny Production
Methods of Treating Wounds Using Il-23
Crystalline Polymorph of a Bisulfate Salt of a Thrombin Receptor Antagonist
High Affinity Ligands for Nociceptin Receptor Orl-1
Use of Mometasone Furoate for Treating Upper Airway Diseases
Use of Mometasone Furoate for Treating Airway Passage and Lung Diseases
Antibodies Specific for Plasmacytoid Dendritic Cells
Mdl-1 Polypeptides
Binding Compounds to DAP12 Proteins
Novel Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Mammalian Cytokines; Related Reagents
Fdf-03 S1 Antigen-Antibody Complex
Crystalline Antifungal Polymorph
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Uses of Il-23 Agonists and Antagonists; Related Reagents
Cannabinoid Receptor Ligands
Soluble, Stable Form of HDM2, Crystalline Forms Thereof and Methods of Use Thereof
Synthesis of 2-Hydroxy-N,N-Dimethyl-3-[[2-[1(R)-(5-Methyl-2-Furanyl)Propyl]Amino]-3,4-Dioxo-1-Cyclobuten-1-Yl]Amino]Benzamide
2-Alkynyl-And 2-Alkenyl-Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidine Adenosine A2A Receptor Antagonists
Process and Intermediates for the Preparation of (1R,2S,5S)-3-Azabicyclo[3,1,0]Hexane-2-Carboxamide, N-[3-Amino-1-(Cyclobutylmethyl)-2,3-Dioxopropyl]-3-[(2S)-2-[[[1,1-Dimethylethyl]Amino]Carbonylamino]-3,3-Dimethyl-1-Oxobutyl]-6,6-Dimethyl
Process and Intermediates for the Preparation of 3-(Amino)-3-Cyclobutylmethyl-2-Hydroxy-Propionamide or Salts Thereof
Process and Intermediates for the Preparation of (1R,2S,5S)-6,6-Dimethyl-3-Azabicyclo[3,1,0]Hexane-2-Carboxylates or Salts Thereof
Cyclic Amine Bace-1 Inhibitors Having a Benzamide Substituent
Cyclic Amine Bace-1 Inhibitors Having a Heterocyclic Substituent
Adenosine A2A Receptor Antagonists
Cytokine Receptor
Crystalline Form of the Catalytic Domain of Aurora 2 Kinase and Methods of Use Thereof
Patent:
7,422,885 →
Application:
10/943,438 →
Macrocyclic Inhibitors of Hepatitis C Virus NS3-Serine Protease
Process for Preparing Substituted 5-Amino-Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidines
[1,2,4]-Triazole Bicyclic Adenosine A2A Receptor Antagonists
Human Receptor Proteins; Related Reagents and Methods
Plasmid System for Multigene Expression
Anti-Igfr Antibody Therapeutic Combinations
Methods for Inhibiting Sterol Absorption
Il-B30 Antibodies
Heterocyclic Aspartyl Protease Inhibitors
Thiadiazoles as Cxc- and Cc- Chemokine Receptor Ligands
Isothiazole Dioxides as Cxc- and Cc-Chemokine Receptor Ligands
Substituted N-Aryl Amidines as Selective D1 Dopamine Receptor Antagonists for the Treatment of Obesity and Cns Disorders
Everninomicin Biosynthetic Genes
Preparation of Powder Agglomerate
17 Beta-Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Imidazopyrazines as Cyclin Dependent Kinase Inhibitors
Use of Agonists and Antagonists of Il-23 in the Treatment of Viral Infection
Pyrazolotriazines as Kinase Inhibitors
Sulfur Compounds as Inhibitors of Hepatitis C Virus NS3 Serine Protease
Novel Compounds as Inhibitors of Hepatitis C Virus NS3 Serine Protease
Novel Inhibitors of Hepatitis C Virus NS3 Protease
Novel Ketoamides with Cyclic P4'S as Inhibitors of NS3 Protease of Hepatitis C Virus
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Antibodies Binding the Tnf Related Protein, Tnf-Y
Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidine Adenosine A2A Receptor Antagonists
Method of Treating Skin Inflammation
CXCR1 and CXCR2 Chemokine Antagonists
Substituted 2-Quinolyl-Oxazoles Useful as PDE4 Inhibitors
2-Alkynyl-And 2-Alkenyl-Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidine Adenosine A2A Receptor Antagonists
Constrained Himbacine Analogs as Thrombin Receptor Antagonists
Compounds for the Treatment of Inflammatory Disorders
Heterocyclic Aspartyl Protease Inhibitors
Cannabinoid Receptor Ligands
Melanoma Therapy
Compounds for the Treatment of Inflammatory Disorders
Substituted Amide Beta Secretase Inhibitors
Macrocyclic Beta-Secretase Inhibitors
Methods of Inhibiting Metastasis
Cannabinoid Receptor Ligands
Stable Pegylated Interferon Formulation
Cannabinoid Receptor Ligands
Heteroaryl Urea Neuropeptide Y Y5 Receptor Antagonists
Acylsulfonamide Compounds as Inhibitors of Hepatitis C Virus NS3 Serine Protease
Reporter Assay Screens for Protein Targets in Saccharomyces Cerevisiae
ERK2 Crystals
Process and Intermediates for the Preparation of 3-(Amino)-3-Cyclobutylmethyl-2-Hydroxy-Propionamide or Salts Thereof
Novel Imidazopyridines as Cyclin Dependent Kinase Inhibitors
Thrombin Receptor Antagonists
Pyrazolopyrimidines as Protein Kinase Inhibitors
Stable Extended Release Oral Dosage Composition
Trisubstituted 7-Aminopyrazolopryimidines
N-Heteroaryl Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Trisubstituted and Tetrasubstituted Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Compounds for the Treatment of Inflammatory Disorders
Piperazine Derivatives Useful as CCR5 Antagonists
Substituted 5-Oxo Pyrazoles and [1,2,4]Triazoles as Antiviral Agents
Compositions and Methods for Short Interfering Nucleic Acid Inhibition of NAV1.8
Novel Imidazopyrazines as Cyclin Dependent Kinase Inhibitors
17 Beta-Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Enantioselective Process
Biomarkers for Pre-Selection of Patients for Anti-IGF1R Therapy
Compounds for the Treatment of Inflammatory Disorders
Substituted Piperazines as CB1 Antagonists
Mammalian Cytokines; Receptors; Related Reagents and Methods
Treatment of Diabetes Using Antibodies to Il-23, Il-23 Receptor and Il-17
Thrombin Receptor Antagonists
Application:
11/311,083 →
Publication:
US US20060106050A1
Pyrazolo [1,5-a] Pyrimidine Adenosine A2A Receptor Antagonists
Preparation of Ketone Amides
Method for Purifying Adenoviruses
Exo-Selective Synthesis of Himbacine Analogs
Synthesis of Himbacine Analogs
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Processes of Making and Using Pharmaceutical Formulations of Antineoplastic Agents
Compounds for the Treatment of Inflammatory Disorders
Pyrazolotriazines as Kinase Inhibitors
Kinase Inhibitors
DNAXCCR10
Heteroaryl Substituted Pyrazinyl-Piperazine-Piperidines with CXCR3 Antagonist Activity
Novel Heterocyclic Substituted Pyridine or Phenyl Compounds with CXCR3 Antagonist Activity
Heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity
Pyridyl and Phenyl Substituted Piperazine-Piperidines with CXCR3 Antagonist Activity
Piperazine-Piperidines with CXCR3 Antagonist Activity
Pyrazinyl Substituted Piperazine-Piperidines with CXCR3 Antagonist Activity
Amine-Linked Pyridyl and Phenyl Substituted Piperazine-Piperidines with CXCR3 Antagonist Activity
Compositions and Methods for Therapeutic Use
17BETA-Hydroxysteroid Dehydrogenase Type 3 Inhibitors for the Treatment of Androgen Dependent Diseases
Treatments for Flaviviridae Virus Infection
Spirocyclic Thrombin Receptor Antagonists
Trisubstituted 4-Aminopyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
N-Heteroaryl Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
N-Heteroaryl Pyrazolopyrimidines as Cyclin Dependent Kinase Inhibitors
Methods and compositions for treating or preventing cancer
Application:
11/404,967 →
Publication:
US US20060233810A1
Synthesis of 2-Hydroxy-N,N-dimethyl-3-[[2-[[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dixo-1cyclobuten-1yl]amino]benzamide
Heterocycles as Nicotinic Acid Receptor Agonists for the Treatment of Dyslipidemia
Anti-CCL27 Antibodies
Administration of Hcv Protease Inhibitors in Combination with Food to Improve Bioavailability
Pharmaceutical Formulations and Methods of Treatment Using the Same
Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
Substituted Isoindolines as Aspartyl Protease Inhibitors
Bicyclic Guanidine Derivatives as Asparyl Protease Inhibitors, Compositions, and Uses Thereof
Substituted Spiro Iminopyrimidinones as Aspartyl Protease Inhibitors, Compositions, and Methods of Treatment
Preparation and Use of Compounds as Aspartyl Protease Inhibitors
Aspartyl Protease Inhibitors
Stable antibody formulation
Application:
11/452,167 →
Publication:
US US20060286103A1
5,6-Di-Substituted Oxadiazolopyrazines and Thiadiazolopyrazines as Cxc-Chemokine Receptor Ligands
Sugar-free storage-stable antihistaminic syrups
Application:
11/477,689 →
Publication:
US US20070009558A1
Il-1-Like Cytokine Antibodies
Methods of Treating Inflammation Using Mammalian CX3C Chemokine Antibodies
3,4-Di-Substituted Cyclobutene-1,2-Diones as Cxc-Chemokine Receptor Ligands
MCP1 Fusions
Compounds for the Treatment of Inflammatory Disorders
Il-12P40 and Il-B30 Polypeptide Complex
Novel High Affinity Quinoline-Based Kinase Ligands
Functionally Selective ALPHA2C Adrenoreceptor Agonists
Engineered Anti-Il-23 Antibodies
2-Heteroaryl-Pyrazolo-[4,3-E]-1,2,4-Triazolo-[1,5-C]-Pyrimidine Adenosine A2A Receptor Antagonists
Pregnane X Receptor Compositions, Crystals and Uses Thereof
Patent:
7,785,879 →
Application:
11/522,698 →
1-[[1-[(2-Amino-6-Methyl-4-Pyridinyl)Methyl]-4-Fluoro-4-Piperidinyl]Carbonyl]-4-[2-(2-Pyridinyl)-3H-Imidazo[4,5-B]Pyridin-3-Yl]Piperidine
NPC1L1 (NPC3) and methods of use thereof
Application:
11/523,512 →
Publication:
US US20070021592A1
7-[2-[4-(6-Fluoro-3-Methyl-1,2-Benzisoxazol-5-Yl)-1-Piperazinyl]Ethyl]-2-(1-Propynyl)-7H-Pyrazolo-[4,3-E]-[1,2,4]-Triazolo-[1,5-C]-Pyrimidin-5AMINE
Substituted Pyrazolo[1,5-a]Pyrimidness as Protein Kinase Inhibitors
Substituted Pyrazolo[1,5-a] Pyrimidines as Protein Kinase Inhibitors
Substituted Pyrazolo[1,5-a]Pyrimidines as Protein Kinase Inhibitors
Substituted Pyrazolo[1,5-a]Pyrimidines as Protein Kinase Inhibitors
Methods for Using Human Monoclonal Antibodies to Interleukin-5
Substituted Pyrazolo[1,5-a]Pyrimidines as Protein Kinase Inhibitors
Substituted Heterocyclic Compounds with CXCR3 Antagonist Activity
Pyrazolotriazines as Kinase Inhibitors
Methods for Identifying Modified Tumor Necrosis Factor-Alpha Converting Enzyme Inhibitors
Heterocyclic Aspartyl Protease Inhibitors
3-Monosubstituted Tropane Derivatives as Nociceptin Receptor Ligands
Nucleic Acids Encoding Human Tnf-a Convertase
Neutralizing Human Anti-Igfr Antibody
Oxidation Process for the Preparation of N-[3-Amino-1-(Cyclobutylmethyl)-2,3-Dioxopropyl]-3-{N-[(Tert-Butylamino)Carbonyl]-3-Methyl-L-Valyl}-6,6-Dimethyl-3-Azabicyclo[3.1.0]Hexane-2-Carboxamide and Related Compounds
Neutralizing Human Anti-Igfr Antibody
Nitrogen-Containing Heterocyclic Compounds and Methods of Use Thereof
Novel Ketoamides with Cyclic P4'S as Inhibitors of NS3 Serine Protease of Hepatitis C Virus
Nucleic Acids Encoding Il-174
Compounds for the Treatment of Inflammatory Disorders and Microbial Diseases
Histamine Receptor
Interleukin-10 Antibodies
Method for Making Beta-Secretase Co-Crystals Complexed with a Ligand
Method of Evaluating Inflammatory Skin Disorders Using Il-17 and/or Il-19
Oxazoloisoquinoline Derivatives as Thrombin Receptor Antagonists
Novel Compounds as Inhibitors of Hepatitis C Virus NS3 Serine Protease
Novel Inhibitors of Hepatitis C Virus NS3 Protease
Thiadiazoledioxides and Thiadiazoleoxides as Cxc- and Cc-Chemokine Receptor Ligands
Compounds for the Treatment of Inflammatory Disorders
Compounds for the Treatment of Inflammatory Disorders
Compounds for the Treatment of Inflammatory Disorders
Benzenesulfonyl-Chromane, Thiochromane, Tetrahydronaphthalene and Related Gamma Secretase Inhibitors
Methods of Modulating Immune Disorders Using Agonists or Antagonists of Il-33
Application:
11/682,224 →
Publication:
US US20070160579A1
Novel Heterocyclic Substituted Pyridine Compounds with CXCR3 Antagonist Activity
ALPHA2C Adrenoreceptor Agonists
Functionally Selective ALPHA2C Adrenoreceptor Agonists
Treatment of Chemokine Mediated Diseases
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compunds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
NPC1L1 Orthologues
Heterocyclic Aspartyl Protease Inhibitors
Substituted Pyrazolo[1,5-a]Pyrimidines as Cyclin Dependent Kinase Inhibitors
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Monocyclic and Bicyclic Himbacine Derivatives Useful as Thrombin Receptor Antagonists
Sulfur Compounds as Inhibitors of Hepatitis C Virus NS3 Serine Protease
Thrombin Receptor Antagonists
Fused Ring Thrombin Receptor Antagonists
Everninomicin Biosynthetic Genes
Use of Il-27 Agonists to Increase Interferon-Gamma Production
Pharmaceutical Compositions for Sustained Release of Phenylephrine
Application:
11/756,774 →
Publication:
US US20070281020A1
Aspartyl Protease Inhibitors
Pharmaceutical Formulations and Compositions of a Selective Antagonist of Either CXCR2 or Both CXCR1 and CXCR2 and Methods of Using the Same for Treating Inflammatory Disorders
Adenosine A2A Receptor Antagonists
Unit Dosage Forms of Temozolomide
Application:
11/767,847 →
Publication:
US US20080319039A1
Substituted Bicyclic and Tricyclic Thrombin Receptor Antagonists
Substituted Piperidines That Increase P53 Activity and the Uses Thereof
IGFBP2 Biomarker
Application:
11/771,454 →
Publication:
US US20080112888A1
Immediate-Release Tablet Formulations of a Thrombin Receptor Antagonist
Application:
11/771,520 →
Publication:
US US20080031943A1
Nitrogen-Containing Heterocyclic Compounds and Methods of Use Thereof
Xinafoate Salt of a Substituted 5-Oxazol-2-Yl-Quinoline Compound
Heterocyclic Substituted Piperazine Compounds with CXCR3 Antagonist Activity
Il-33 Receptor
Patent:
7,560,530 →
Application:
11/779,755 →
Process for Preparing Substituted 5-Amino-Pyrazolo-[4,3-E]-1,2,4-Triazolo[1,5-C]Pyrimidines
Substituted Pyrazolo[1,5-a]pyrimidines as Cyclin Dependent kinase Inhibitors
Substituted Pyrazolo[1,5-a]Pyrimidines as Cyclin Dependent Kinase Inhibitors
Process for the Preparation of 6,6-Dimethyl-3-Azabicyclo-[3.1.0]-Hexane Compounds and Enantiomeric Salts Thereof
Novel Compounds That Are Erk Inhibitors
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Synthesis of 3-(5-Nitrocyclohex-1-Enyl) Acrylic Acid and Esters Thereof
Neutralizing Human Anti-Igfr Antibody
Antibodies to Il-17A
Mammalian Cell Surface Antigens; Related Reagents
Application:
11/836,456 →
Publication:
US US20090092597A1
1-[[1-[(2-Amino-6-Methyl-4-Pyridinyl)Methyl]-4-Fluoro-4-Piperidinyl]Carbonyl]-4-[2-(2-Pyridinyl)-3H-Imidazo[4,5-B]Pyridin-3-Yl]Piperidine and Methods of Use Thereof
Hydantoin Derivatives Useful as Antibacterial Agents
Polynucleotides Encoding Polypeptide Fragments of Protein Kinase B Gamma (AKT3)
Patent:
7,776,589 →
Application:
11/847,801 →
Xanthine Phosphodiesterase V Inhibitors
Azetidinone Derivatives and Methods of Use Thereof
Thiadiazoles as Cxc- and Cc- Chemokine Receptor Ligands
Bicyclic and Tricyclic Derivatives as Thrombin Receptor Antagonists
Methods for Crystallizing ERK2 Polypepides
Pharmaceutical Compositions
Application:
11/887,642 →
Publication:
US US20090298802A1
Process and Intermediates for the Synthesis of 2-(Quinolin-5-Yl)-4,5 Disubstituted-Azole Derivatives
Maleate, Tosylate, Fumarate and Oxalate Salts of 5-(1-(S)-Amino-2-Hydroxyethyl)-N-[(2,4-Difluorophenyl)-Methy]-2-[8-Methoxy-2-(Triflouromethy)-5-Quinoline]-4-Oxazolecarboxamide and Preparation Process Therefore
Process for Resolving Chiral Piperidine Alcohol and Process for Synthesis of Pyrazolo[1,5-a] Pyrimidine Derivatives Using Same
Process and Intermediates for the Synthesis of (3-Alkyl-5-Piperidin-1-Yl-3,3A-Dihydro-Pyrazolo[1,5-a]Pyrimidin-7-Yl)-Amino Derivatives and Intermediates
Monoclonal Antibodies to Human Ctla-8 (Il-17A)
Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
Application:
11/931,408 →
Publication:
US US20110150835A1
Preparation of Powder Agglomerates
Process for Producing Metered Dose Inhaler Formulations
Application:
11/948,688 →
Publication:
US US20080066744A1
Purified Mammalian Cytokine Il-174 Polypeptides
Il-17-Like Cytokine Binding Compounds and Antibodies
DAP12 Nucleic Acids
Hiv Gene Cloning Strategy
Application:
11/963,007 →
Publication:
US US20080220528A1
G-Protein Coupled Receptor Ligands and Methods
Process and Intermediates for the Preparation of (1R,2S,5S)-6,6-Dimethyl-3-Azabicyclo[3,1,0]Hexane-2-Carboxylates for Salts Thereof
Plasmid System for Multigene Expression
Method for Determinin the Presence of Proteolytic Activity in a Sample
Application:
12/001,658 →
Publication:
US US20090294288A1
Methods of Treating Cutaneous Ulcers and Grafts Using Il-23
DIRS1 Polypeptides
Methods of Modulating CD200 Receptors
Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors
Piperazine Derivatives Useful as CCR5 Antagonists
Process for the Precipitation and Isolation of 6,6-Dimethyl-3-Aza-Bicyclo [3.1.0] Hexane-Amide Compounds by Controlled Precipitation and Pharmaceutical Formulations Containing Same
Human Dnax Toll-Like Receptor 4 Proteins, Related Reagents and Methods
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof
Preparation of Powder Agglomerates
Novel Heterocyclic Substituted Pyridine or Phenyl Compounds with CXCR3 Antagonist Activity
Treating Allergic and Inflammatory Conditions
Il-1-Like Cytokine
Treatment Methods
Application:
12/171,989 →
Publication:
US US20090022671A1
Crystalline Polymorphs of a Cxc-Chemokine Receptor Ligand
Antibodies to IL-B50
Il-B50 Polypeptide
Method for Raising or Isolating an Antibody to DCRS5
Mammalian Receptor Protein DCRS5; Methods of Treatment
Method for Crystallizing Aurora 2 Kinase Catalytic Domain Polypeptide
Mammalian CX3C Chemokine Antibodies
Method of Treating Skin Inflammation
Method of Treatment of Skin Inflammation
Process for Preparing Substituted 5-Amino-Pyrazolo-[4,3-E]-1,2,4-Triazolo[1,5-C]Pyrimidines
Mammalian Genes; Related Reagents and Methods
Methods of Modulating
Application:
12/239,689 →
Publication:
US US20090041718A1
HDM2 Polypeptides
Patent:
7,705,127 →
Application:
12/249,314 →
Synthesis of 2-Hydroxy-N,N-Dimethyl-3-[[2-[[1(R)-(5-Methyl-2-Furanyl)Propyl]Amino]-3,4-Dioxo-1-Cyclobuten-1-Yl]Amino]Benzamide
Antibodies That Bind Dnax Leukocyte Associated Immunoglobulin-Like Receptor
Synthesis of 3-(5-Nitrocyclohex-1-Enyl) Acrylic Acid and Esters Thereof
Heterocyclic Aspartyl Protease Inhibitors
Compounds for the Treatment of Inflammatory Disorders
3-Monosubstituted Tropane Derivatives as Nociceptin Receptor Ligands
Compounds for the Treatment of Inflammatory Disorders
Compounds for the Treatment of Inflammatory Disorders
3,4-Di-Substituted Cyclobutene-1,2-Diones as Cxc-Chemokine Receptor Ligands
Compounds for the Treatment of Inflammatory Disorders
Engineered Anti-Il-23 Antibodies
Method of Treating Hepatitis C Patients
Application:
12/376,180 →
Publication:
US US20100226885A1
Pharmaceutical Formulations of Antineoplastic Agents
Treatments for Flaviviridae Virus Infection
Il-D80 Polypeptides and Il-27
Modified Tumor Necrosis Factor-Alpha Converting Enzyme and Methods of Use Thereof
Synthesis of Himbacine Analogs
Refolded Recombinant Beta-Secretase Crystals and Methods for Preparing and Using the Same
Factor Ixa Crystals, Related Complexes and Methods
Patent:
7,968,683 →
Application:
12/437,116 →
2-Aminothiazole-4-Carboxylic Amides as Protein Kinase Inhibitors
2-Aminothiazole-4-Carboxylic Amides as Protein Kinase Inhibitors
Pharmaceutical Formulation
Heterocyclic Aspartyl Protease Inhibitors
Monocyte-Derived Nucleic Acids and Related Compositions and Methods
Methods of making antibodies specific for cysteine-rich soluble protein C23
Cyclic Amine Bace-1 Inhibitors Having a Heterocyclic Substituent
Assay for PCSK9 Inhibitors
Patent:
8,206,943 →
Application:
12/493,752 →
Method of Treatment Using an Anti-Il-B50 Antibody
7-[2-[4-(6-Fluoro-3-Methyl-1,2-Benzisoxazol-5-Yl)-1-Piperazinyl]Ethyl]-2-(1-Propynyl)-7H-Pyrazolo-[4,3-E]-[1,2,4]-Triazolo-[1,5-C]-Pyrimidin-5-Amine
Methods or Modulating Immune Disorders Using Il-33 Receptor Antagonists
Patent:
8,187,596 →
Application:
12/501,870 →
Exo- and Diastereo- Selective Syntheses of Himbacine Analogs
Agonist Antibodies to Il-23 Receptor
Mammalian CX3C Chemokine Antibodies
Combination Therapy for Proliferative Disorders
Application:
12/514,758 →
Publication:
US US20100143332A1
Engineered Anti-Tslp Antibody
Methods of Modulating Maternal-Fetal Tolerance Comprising Administration of Il-27
Application:
12/516,458 →
Publication:
US US20100150862A1
Ph Sensitive Matrix Formulation
Application:
12/517,317 →
Publication:
US US20100081672A1
Aspartyl Protease Inhibitors
Methods and Compositions for Treating Cancer
Application:
12/518,405 →
Publication:
US US20100143340A1
Methods of Treatment
Application:
12/518,409 →
Publication:
US US20110262525A1
Process for Preparing (1R,2S,5S)-N-[(1S)-3-Amino-1-(Cyclobutylmethyl)-2,3-Dioxopropyl]-3-[(2S)-2-[[[(1,1-Dimethylethyl)Amino]-Carbonyl]Amino]-3,3-Dimethyl-1-Oxobutyl]-6,6-Dimethyl-3-Azabicyclo[3.1.0]Hexane-2-Carboxamide
Process for the Preparation of 6,6-Dimethyl-3-Azabicyclo-[3.1.0]- Hexane Compounds Utilizing Bisulfite Intermediate
4,5-Ring Annulated Indole Derivatives for Treating or Preventing of Hcv and Related Viral Infections
4, 5-Ring Annulated Indole Derivatives for Treating or Preventing of Hcv and Related Viral Infections
Novel Substituted Pyridines That Are Jnk Inhibitors
Heterocyclic Compounds with CXCR3 Antagonist Activity
Application:
12/519,970 →
Publication:
US US20120157466A1
5, 6-Ring Annulated Indole Derivatives and Use Thereof
Antibodies to CD200R
Dispenser Dose Counter Mechanism
Application:
12/520,069 →
Publication:
US US20100083964A1
Dose Counter Mechanism
Application:
12/520,071 →
Publication:
US US20100263665A1
Methods to Treat and/or Prevent Mucositis
Use of Il-23 Antagonists for Treatment of Infection
Functionally Selective ALPHA2C Adrenoreceptor Agonists
Derivatives and Analogs of Chroman as Functionally Selective ALPHA2C Adrenoreceptor Agonists
Functionally Selective ALPHA2C Adrenoreceptor Agonists
Engineered Anti-Il-23P19 Antibodies
Engineered Anti-Il-23R Antibodies
Engineered Anti-Il-23P19 Antibodies
Application:
12/527,456 →
Publication:
US US20100111966A1
Method of Treating an Autoimmune Disease with a Binding Compound Comprising Antibodies to Il-23R and CD161
Application:
12/527,459 →
Publication:
US US20100135998A1
Methods of Inhibiting Tumor Growth Using Blocking Antibodies to Il-23R
Uses of Mammalian Cytokines and Agonists; Related Reagents
Nucleic Acids Encoding CCL27
Substituted Piperazines as CB1 Antagonists
Macrocyclic Beta-Secretase Inhibitors
Il-B30 Antibodies
Compounds for the Treatment of Inflammatory Disorders
Pyrimidinone Derivatives and Methods of Use Thereof
Anti-Mdl-1 Antibodies
Methods of Treatment Using Intravenous Formulations Comprising Temozolomide
Application:
12/598,012 →
Publication:
US US20100210700A1
Gamma Secretase Modulators
Gamma Secretase Modulators
Gamma Secretase Modulators
Synthesis of Substituted-3-Aminopyrazoles
Application:
12/602,716 →
Publication:
US US20120029204A1
Nucleic Acids Encoding Murine Il-174
Mammalian Expression Vector Puhab
Macrocyclic Heterocyclic Aspartyl Protease Inhibitors
Methods for Treating Rheumatoid Arthritis and Multiple Sclerosis Using MCP1 Fusions
Polynucleotides Encoding Soluble, Stable Forms of Human Double Minute 2 Polypeptides
Pharmaceutical Compositions for the Treatment of Asthma
Application:
12/633,510 →
Publication:
US US20100143269A1
Cyclic Amine Bace-1 Inhibitors Having a Benzamide Substituent
Novel Heterocyclic Substituted Pyridine Compounds with CXCR3 Antagonist Activity
Use of Il-23 and Il-17 Antagonists to Treat Autoimmune Ocular Inflammatory Disease
Use of Il-23 and Il-17 Antagonists to Treat Autoimmune Ocular Inflammatory Disease
Application:
12/643,166 →
Publication:
US US20100111954A1
Mammalian Genes; Related Reagents and Methods
Joint Destruction Biomarkers for Anti-Il-17A Therapy of Inflammatory Joint Disease
Application:
12/663,381 →
Publication:
US US20100239590A1
Anti-IGF1R
Application:
12/663,651 →
Publication:
US US20110014117A1
Polycyclic Guanine Derivatives and Use Thereof
Mdl-1 Uses
Application:
12/665,009 →
Publication:
US US20100221252A1
Process for Controlled Crystal Size in 1,2-Substituted 3,4-Dioxo-1-Cyclobutene Compounds
Application:
12/665,290 →
Publication:
US US20100249439A1
Tetrahydropyranochromene Gamma Secretase Inhibitors
Process and Intermediates for the Synthesis of 1,2-Substituted 3,4-Dioxo-1-Cyclobutene Compounds
Hydrogen Chloride Salt of a Substituted 5-Oxazol-2-Yl-Quinoline Compound and a Process for the Production Thereof
Application:
12/668,191 →
Publication:
US US20110003780A1
Benzenesulfonyl-Chromane, Thiochromane, Tetrahydronaphthalene and Related Gamma Secretase Inhibitors
Heterocyclic Amide Compounds as Protein Kinase Inhibitors
Gamma Secretase Modulators
Application:
12/671,782 →
Publication:
US US20110257163A1
Gamma Secretase Modulators
Application:
12/671,806 →
Publication:
US US20110009392A1
6-SUBSTITUTED SULFONYL AZABICYCLO[3.2.1]OCTANES USEFUL TO INHIBIT 11Beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1
SUBSTITUTED BICYCLIC PIPERIDINYL-AND PIPERAZINYL- SULFONAMIDES USEFUL TO INHIBIT 11beta-HYDROXYSTEROID DEHYDROGENASE TYPE-1
Substituted Azepine- and Diazepine-Sulfonamides Useful to Inhibit 11BETA-Hydroxysteroid Dehydrogenase Type-1
Application:
12/672,826 →
Publication:
US US20110129542A1
Gamma Secretase Modulators
2,3-Substituted Azaindole Derivatives for Treating Viral Infections
Tetracyclic Indole Derivatives and Their Use for Treating or Preventing Viral Infections
Application:
12/675,277 →
Publication:
US US20110104109A1
Substituted Indole Derivatives and Methods of Use Thereof
2,3-Substituted Indole Derivatives for Treating Viral Infections
Gamma Secretase Modulators
Application:
12/676,035 →
Publication:
US US20100298381A1
Formulation Containing Cyclin-Dependent Kinase Inhibiting Compound and Method of Treating Tumors Using the Same
Application:
12/678,320 →
Publication:
US US20100286038A1
Methods for Inhibiting Protein Kinases
Compounds for the Treatment of Inflammatory Disorders
Heterocyclic Aspartyl Protease Inhibitors
Synthesis of Diethyl{[5-(3-Fluorophenyl)-Pyridine-2YL]Methyl}Phosphonate
Interleukin-10 Antibodies
Modified Tumor Necrosis Factor-Alpha Converting Enzyme and Methods of Use Thereof
Uses of Mammalian Cytokine; Related Reagents
Application:
12/709,162 →
Publication:
US US20100143357A1
ALPHA2C Adrenoreceptor Agonists
HDM2 Polypeptides
C20-C21 Substituted Glucocorticoid Receptor Agonists
C21 Thioethers as Glucocorticoid Receptor Agonists
Application:
12/736,064 →
Publication:
US US20110262368A1
Thiazole Derivatives as Protein Kinase Inhibitors
Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof
Application:
12/738,521 →
Publication:
US US20110129440A1
Compounds for Inhibiting Ksp Kinesin Activity
Application:
12/738,529 →
Publication:
US US20110150757A1
Thiazole Carboxamide Derivatives and Their Use to Treat Cancer
Compounds for Inhibiting Ksp Kinesin Activity
Compounds for Inhibiting Ksp Kinesin Activity
Application:
12/738,540 →
Publication:
US US20110171172A1
Gamma Secretase Modulators
Fully Human Anti-Vegf Antibodies and Methods of Using
Bicyclic Heterocycle Derivatives and Their Use as Modulators of the Activity of GPR119
Anti-PCSK9 and Methods for Treating Lipid and Cholesterol Disorders
3-Heterocyclic Substituted Indole Derivatives and Methods of Use Thereof
3-Aminosulfonyl Substituted Indole Derivatives and Methods of Use Thereof
Novel Modulators of Cell Cycle Checkpoints and Their Use in Combination with Checkpoint Kinase Inhibitors
Morpholinone Compounds as Factor Ixa Inhibitors
Braf Biomarkers
Application:
12/745,031 →
Publication:
US US20110158944A1
Gamma Secretase Modulators
Methods of Treating Copd
Application:
12/746,232 →
Publication:
US US20110009482A1
Gamma Secretase Modulators
Application:
12/746,313 →
Publication:
US US20100298359A1
Gamma Secretase Modulators
Application:
12/747,001 →
Publication:
US US20100298372A1
Gamma Secretase Modulators
Process for the Preparation of 6,6-Dimethyl-3-Azabicyclo-[3.3.0]-Hexane Compounds and Enantiomeric Salts Thereof
Mammalian Cytokines; Related Reagents and Methods
Kinase Domain Polypeptide of Human Protein Kinase B Gamma (AKT3)
Use of Bispecific Antibodies to Regulate Immune Responses
Compositions and Methods for Short Interfering Nucleic Acid Inhibition of NAV1.8
Heterocyclic Aspartyl Protease Inhibitors
Biomarkers for Sensitivity to Anti-IGF1R Therapy
Application:
12/808,270 →
Publication:
US US20110091524A1
Methods for Inhibiting Tumor Growth or Reducing Metastatic Burden in a Subject by Administering FDF03 Antibodies
Process For the Synthesis of 3- Amino-3-Cyclobuthylmethyl-2-Hydroxypropionamide or Salts Thereof
Inhalation Drug Products, Systems and Uses
Application:
12/812,287 →
Publication:
US US20110182830A1
Crystal of Pregnane X Receptor Fused to Steroid Receptor Coactivator-1
DCRS5 Polypeptides
Method of Treating Skin Inflammation
Exo-Selective Synthesis of Himbacine Analogs
Mouse CX3C Chemokine Polypeptides
Mammalian Receptor Proteins DCRS5; Method of Treatment
SYN3 Compositions and Methods
Combinations of Hcv Protease Inhibitor(S) and CYP3A4 Inhibitor(S), and Methods of Treatment Related Thereto
Application:
12/839,097 →
Publication:
US US20100291034A1
Processes of Making Pharmaceutical Formulations of Antineoplastic Agents
Substituted Amide Beta Secretase Inhibitors
Engineered Anti-Tslpr Antibodies
Tetrahydropyranochromene Gamma Secretase Inhibitors
Application:
12/869,010 →
Publication:
US US20110054013A1
Everninomicin Biosynthetic Genes
Nucleic Acids Encoding Engineered Anti-Il-23 Antibodies
Application:
12/882,035 →
Publication:
US US20110002942A1
Uses of Mammalian Cytokine; Related Reagents
Application:
12/884,493 →
Publication:
US US20110002928A1
Antibodies and Functional Fragments Thereof That Specifically Bind an Rf-Amide Peptide or a Precursor Thereof
Antibodies to Il-17A
Antibodies to Il-17A
Novel Compounds That Are Erk Inhibitors
Functionally Selective ALPHA2C Adrenoreceptor Agonists
CCR5 Antagonists as Prophylactics for Preventing Hiv Infection and Methods of Inhibiting Transmission of Same
Application:
12/919,833 →
Publication:
US US20110059154A1
1,2,4-Triazolo[4,3-C]Pyrimidin-3-One and Pyrazolo[4,3-E]-1,2,4-Triazolo[4,3-C]Pyrimidin-3-One Compounds for Use as Adenosine A2A Receptor Antagonists
AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
Methods for Treating or Preventing Colorectal Cancer
Application:
12/934,458 →
Publication:
US US20110104256A1
Oral Pharmaceutical Compositions in a Solid Dispersion Comprising Preferably Posaconazole and HPMCAs
Application:
12/937,881 →
Publication:
US US20110034478A1
Neutralizing Human Anti-Igfr Antibody
Heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity
Novel Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Application:
12/973,020 →
Publication:
US US20110117057A1
NUCLEIC ACID ENCODING TNFx PROTEIN
Method of Treating Solid Cancers with Pegylated Il-10
Mammalian Cytokines; Related Reagents and Methods
Application:
12/984,523 →
Publication:
US US20110177022A1
Phenyl-Substituted 2-Imino-3-Methyl Pyrrolo Pyrimidinone Compounds as Bace-1 Inhibitors, Compositions, and Their Use
Thiophenyl-Substituted 2-Imino-3-Methyl Pyrrolo Pyrimidinone Compounds as Bace-1 Inhibitors, Compositions, and Their Use
Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer
Application:
12/991,228 →
Publication:
US US20110129456A1
Glucagon Receptor Antagonists, Compositions, and Methods for Their Use
Bicyclic Heterocycle Derivatives and Use Thereof as GPR119 Modulators
Application:
12/993,363 →
Publication:
US US20110065671A1
Heterocyclic Compounds as Factor Ixa Inhibitors
Method of Reducing Total Cholesterol Level by Administering Matrilin-2 Polypeptide
Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and HPMCAs
Application:
12/999,547 →
Publication:
US US20110123627A1
Bicyclic Heterocycle Derivatives and Use Thereof as GPR119 Modulators
Bicyclic Heterocycle Derivatives and Methods of Use Thereof
Mammalian receptor protein DCRS5; methods of treatment
Il-D80 Polynucleotides
Methods of Treating Cutaneous Ulcers and Grafts Using Agonist Antibodies to Il-23 Receptor
NPC1L1 Orthologues
Engineered Anti-Il-23P19 Antibodies
Fused Tricyclic Silyl Compounds and Methods of Use Thereof for the Treatment of Viral Diseases
Intranasal Compositions, Dosage Forms and Methods of Treatment
Application:
13/054,242 →
Publication:
US US20110189106A1
Pharmaceutical Formulations of an Hcv Protease Inhibitor in a Solid Molecular Dispersion
Application:
13/057,339 →
Publication:
US US20110207660A1
Il-8 Biomarker for Monitoring Cancer Treatment with Certain Erk Inhibitors
Engineered Anti-IL-23R Antibodies
Application:
13/060,665 →
Publication:
US US20110158992A1
Lyophilized Formulations of Engineered Anti-Il-23P19 Antibodies
Peptides as NS3-Serine Protease Inhibitors of Hepatitis C Virus
Patent:
43,298 →
Application:
13/068,159 →
Il-1-Like Cytokine Antibodies
Pulmonary Disease Treatment
Application:
13/093,307 →
Publication:
US US20110200647A1
A Method for Treating Atherosclerosis by Administering Human MCP1 Fusions
Everninomicin Biosynthetic Genes
Application:
13/098,645 →
Publication:
US US20110269216A1
MCP1-Ig Fusion Variants
Heterocyclic Aspartyl Protease Inhibitors
High Titer Antibody Production
Application:
13/120,558 →
Publication:
US US20110229933A1
Compounds for the Treatment of Inflammatory Diseases
Spiro-Imidazolone Derivatives as Glucagon Receptor Antagonists
Corticosteroid Compositions and Methods of Treatments Thereof
Application:
13/123,670 →
Publication:
US US20120022032A1
Gamma Secretase Modulators
Application:
13/125,995 →
Publication:
US US20110263529A1
Gamma Secretase Modulators
Application:
13/126,056 →
Publication:
US US20110257156A1
Inflammatory Bowel Disease Biomarkers and Related Methods of Treatment
Application:
13/127,212 →
Publication:
US US20110212104A1
Inhibitors of Fatty Acid Binding Protein (Fabp)
Gamma Secretase Modulators
Gamma Secretase Modulators
Beta G1-Igg Intron for Enhanced Anti-IGF1R Expression
Piperidine and Piperazine Derivatives and Methods of Use Thereof
Application:
13/139,639 →
Publication:
US US20110245267A1
Bicyclic Heterocyclic Derivatives and Methods of Use Thereof
Feed Supplement for Mammalian Cell Culture and Methods of Use
Application:
13/140,794 →
Publication:
US US20110250644A1
Gamma Secretase Modulators
Pyrimidine Derivatives as Gpcr Modulators for Use in the Treatment of Obesity and Diabetes
Purification of Recombinantly Produced Interferon
Application:
13/141,269 →
Publication:
US US20110257368A1
Bicyclic Heterocycle Derivatives and Methods of Use Thereof
Pentafluorosulpholane-Containing Antidiabetic Compounds
Application:
13/145,025 →
Publication:
US US20110313008A1
Bridged and Fused Antidiabetic Compounds
Application:
13/145,152 →
Publication:
US US20110312967A1
Phthalazine-Containing Antidiabetic Compounds
Nucleic Acids Encoding DCRS5
Isolated Mammalian Monocyte Cell Genes; Related Reagents
Application:
13/190,247 →
Publication:
US US20120020990A1
Heterocyclic Aspartyl Protease Inhibitors
Bicyclic Compounds as Inhibitors of Diacylglycerol Acyltransferase
Pegylated Interleukin-10
Monocyte-Derived Nucleic Acids and Related Compositions and Methods
Pharmaceutical Formulations
Application:
13/251,899 →
Publication:
US US20120022094A1
Bicyclic Piperidine and Piperazine Derivatives as Gpcr Modulators for the Treatment of Obesity, Diabetes and Other Metabolic Disorders
Bridged Bicyclic Heterocycle Derivatives and Methods of Use Thereof
Application:
13/260,950 →
Publication:
US US20120040975A1
Agglomerate Formulations Including Active Pharmaceutical Agents with Targeted Particle Sizes
Application:
13/266,067 →
Publication:
US US20120097160A1
Uses of Il-23 Agonists and Antagonists; Related Reagents
Application:
13/270,077 →
Publication:
US US20120034219A1
NPC1L1 (NPC3) and Methods of Use Thereof
Application:
13/271,348 →
Publication:
US US20120079616A1
Plasmid System for Multigene Expression
Methods of Treating Cutaneous Ulcers and Grafts Using Nucleic Acids Encoding Il-23
Application:
13/286,948 →
Publication:
US US20120052044A1
Methods of Treatment Using an Anti Il B50 Antibody
Application:
13/287,456 →
Publication:
US US20120177658A1
Processes of Making and Using Pharmaceutical Formulations of Antineoplastic Agents
Stable Pharmaceutical Drug Products
Application:
13/297,866 →
Publication:
US US20120055469A1
Preparation of Ketone Amides
Application:
13/303,272 →
Publication:
US US20120065397A1
Spiro 1,3,4-Thiadiazoline Derivatives as Ksp Inhibitors
Application:
13/320,069 →
Publication:
US US20120070370A1
Modulation of Pilr Receptors to Treat Microbial Infections
Application:
13/321,397 →
Publication:
US US20120128673A1
Modulation of Pilr Receptors to Treat Sepsis
Application:
13/321,406 →
Publication:
US US20120121588A1
Binding Compounds for Il-27
Mammalian Cell Surface Antigens; Related Reagents
Application:
13/331,879 →
Publication:
US US20120094937A1
Mammalian Receptor Proteins; Related Reagents and Methods
Application:
13/350,627 →
Publication:
US US20120121601A1
Mammalian Receptor Proteins DCRS5; Methods of Treatment
Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
Application:
13/357,962 →
Publication:
US US20120141411A1
Use of Mometasone Furoate for Treating Airway Passage and Lung Disease
Application:
13/366,971 →
Publication:
US US20120134935A1
Engineered Anti-Il-23R Antibodies
Bispecific Antibodies to CD161 and Il-23R and Antigen Binding Fragments Thereof
Application:
13/405,024 →
Publication:
US US20120156699A1
Nucleic Acids Encoding Tnfy
Novel Pyrrolidines as Glucagon Receptor Antagonists, Compositions, and Methods for Their Use
Nozzle for Nasal Spray Device
Patent:
650,065 →
Application:
29/327,288 →
Container with Viewing Window
Patent:
634,641 →
Application:
29/327,289 →
Container with Side Viewing Window
Patent:
624,421 →
Application:
29/327,290 →
Container with Viewing Window
Patent:
607,728 →
Application:
29/327,295 →
Container with Side Viewing Window
Patent:
607,729 →
Application:
29/327,296 →
Asymmetric Process for Preparing Florfenicol, Thiamphenicol Chloramphenicol and Oxazoline Intermediates
Patent:
5,352,832 →
Application:
07/993,932 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.